nodes	percent_of_prediction	percent_of_DWPC	metapath
Meloxicam—PGD—Methotrexate—testicular cancer	0.236	0.305	CbGbCtD
Meloxicam—PTGS1—Ifosfamide—testicular cancer	0.102	0.132	CbGbCtD
Meloxicam—ABCC4—Methotrexate—testicular cancer	0.0651	0.0842	CbGbCtD
Meloxicam—CYP2C8—Ifosfamide—testicular cancer	0.0591	0.0763	CbGbCtD
Meloxicam—PTGS2—Cisplatin—testicular cancer	0.0589	0.0762	CbGbCtD
Meloxicam—PTGS2—Etoposide—testicular cancer	0.0579	0.0749	CbGbCtD
Meloxicam—PTGS1—Etoposide—testicular cancer	0.0489	0.0632	CbGbCtD
Meloxicam—CYP2C9—Ifosfamide—testicular cancer	0.0412	0.0533	CbGbCtD
Meloxicam—CYP2C8—Etoposide—testicular cancer	0.0282	0.0365	CbGbCtD
Meloxicam—CYP3A4—Ifosfamide—testicular cancer	0.024	0.031	CbGbCtD
Meloxicam—CYP2C9—Cisplatin—testicular cancer	0.02	0.0259	CbGbCtD
Meloxicam—CYP3A4—Vinblastine—testicular cancer	0.0127	0.0164	CbGbCtD
Meloxicam—CYP3A4—Etoposide—testicular cancer	0.0114	0.0148	CbGbCtD
Meloxicam—CYP3A4—Doxorubicin—testicular cancer	0.00781	0.0101	CbGbCtD
Meloxicam—Rhinitis—Epirubicin—testicular cancer	0.000157	0.000695	CcSEcCtD
Meloxicam—Abdominal pain—Etoposide—testicular cancer	0.000157	0.000695	CcSEcCtD
Meloxicam—Body temperature increased—Etoposide—testicular cancer	0.000157	0.000695	CcSEcCtD
Meloxicam—Conjunctivitis—Doxorubicin—testicular cancer	0.000157	0.000695	CcSEcCtD
Meloxicam—Urinary tract infection—Doxorubicin—testicular cancer	0.000157	0.000695	CcSEcCtD
Meloxicam—Haemorrhage—Epirubicin—testicular cancer	0.000157	0.000693	CcSEcCtD
Meloxicam—Hepatitis—Epirubicin—testicular cancer	0.000157	0.000693	CcSEcCtD
Meloxicam—Eye disorder—Methotrexate—testicular cancer	0.000157	0.000692	CcSEcCtD
Meloxicam—Tinnitus—Methotrexate—testicular cancer	0.000156	0.000691	CcSEcCtD
Meloxicam—Asthenia—Cisplatin—testicular cancer	0.000156	0.000688	CcSEcCtD
Meloxicam—Pharyngitis—Epirubicin—testicular cancer	0.000156	0.000688	CcSEcCtD
Meloxicam—Cardiac disorder—Methotrexate—testicular cancer	0.000156	0.000688	CcSEcCtD
Meloxicam—Sweating—Doxorubicin—testicular cancer	0.000155	0.000685	CcSEcCtD
Meloxicam—Urinary tract disorder—Epirubicin—testicular cancer	0.000155	0.000685	CcSEcCtD
Meloxicam—Oedema peripheral—Epirubicin—testicular cancer	0.000155	0.000683	CcSEcCtD
Meloxicam—Haematuria—Doxorubicin—testicular cancer	0.000154	0.000681	CcSEcCtD
Meloxicam—Connective tissue disorder—Epirubicin—testicular cancer	0.000154	0.000681	CcSEcCtD
Meloxicam—Urethral disorder—Epirubicin—testicular cancer	0.000154	0.00068	CcSEcCtD
Meloxicam—Hepatobiliary disease—Doxorubicin—testicular cancer	0.000153	0.000676	CcSEcCtD
Meloxicam—Angiopathy—Methotrexate—testicular cancer	0.000152	0.000672	CcSEcCtD
Meloxicam—Sinusitis—Doxorubicin—testicular cancer	0.000152	0.00067	CcSEcCtD
Meloxicam—Immune system disorder—Methotrexate—testicular cancer	0.000152	0.000669	CcSEcCtD
Meloxicam—Visual impairment—Epirubicin—testicular cancer	0.000151	0.000668	CcSEcCtD
Meloxicam—Mediastinal disorder—Methotrexate—testicular cancer	0.000151	0.000668	CcSEcCtD
Meloxicam—Agranulocytosis—Doxorubicin—testicular cancer	0.000151	0.000667	CcSEcCtD
Meloxicam—Nausea—Ifosfamide—testicular cancer	0.00015	0.000661	CcSEcCtD
Meloxicam—Diarrhoea—Cisplatin—testicular cancer	0.000149	0.000656	CcSEcCtD
Meloxicam—Erythema multiforme—Epirubicin—testicular cancer	0.000148	0.000656	CcSEcCtD
Meloxicam—Alopecia—Methotrexate—testicular cancer	0.000148	0.000655	CcSEcCtD
Meloxicam—Mental disorder—Methotrexate—testicular cancer	0.000147	0.000649	CcSEcCtD
Meloxicam—Eye disorder—Epirubicin—testicular cancer	0.000147	0.000648	CcSEcCtD
Meloxicam—Hypersensitivity—Etoposide—testicular cancer	0.000147	0.000647	CcSEcCtD
Meloxicam—Tinnitus—Epirubicin—testicular cancer	0.000146	0.000646	CcSEcCtD
Meloxicam—Malnutrition—Methotrexate—testicular cancer	0.000146	0.000645	CcSEcCtD
Meloxicam—Erythema—Methotrexate—testicular cancer	0.000146	0.000645	CcSEcCtD
Meloxicam—Haemoglobin—Doxorubicin—testicular cancer	0.000146	0.000645	CcSEcCtD
Meloxicam—Flushing—Epirubicin—testicular cancer	0.000146	0.000644	CcSEcCtD
Meloxicam—Cardiac disorder—Epirubicin—testicular cancer	0.000146	0.000644	CcSEcCtD
Meloxicam—Rhinitis—Doxorubicin—testicular cancer	0.000146	0.000643	CcSEcCtD
Meloxicam—Haemorrhage—Doxorubicin—testicular cancer	0.000145	0.000642	CcSEcCtD
Meloxicam—Hepatitis—Doxorubicin—testicular cancer	0.000145	0.000642	CcSEcCtD
Meloxicam—Pharyngitis—Doxorubicin—testicular cancer	0.000144	0.000637	CcSEcCtD
Meloxicam—Urinary tract disorder—Doxorubicin—testicular cancer	0.000143	0.000634	CcSEcCtD
Meloxicam—Oedema peripheral—Doxorubicin—testicular cancer	0.000143	0.000632	CcSEcCtD
Meloxicam—Dysgeusia—Methotrexate—testicular cancer	0.000143	0.000632	CcSEcCtD
Meloxicam—Asthenia—Etoposide—testicular cancer	0.000143	0.000631	CcSEcCtD
Meloxicam—Connective tissue disorder—Doxorubicin—testicular cancer	0.000143	0.00063	CcSEcCtD
Meloxicam—Angiopathy—Epirubicin—testicular cancer	0.000142	0.000629	CcSEcCtD
Meloxicam—Urethral disorder—Doxorubicin—testicular cancer	0.000142	0.000629	CcSEcCtD
Meloxicam—Immune system disorder—Epirubicin—testicular cancer	0.000142	0.000626	CcSEcCtD
Meloxicam—Mediastinal disorder—Epirubicin—testicular cancer	0.000141	0.000625	CcSEcCtD
Meloxicam—Back pain—Methotrexate—testicular cancer	0.000141	0.000624	CcSEcCtD
Meloxicam—Pruritus—Etoposide—testicular cancer	0.000141	0.000622	CcSEcCtD
Meloxicam—Arrhythmia—Epirubicin—testicular cancer	0.00014	0.000619	CcSEcCtD
Meloxicam—Visual impairment—Doxorubicin—testicular cancer	0.00014	0.000618	CcSEcCtD
Meloxicam—Alopecia—Epirubicin—testicular cancer	0.000139	0.000613	CcSEcCtD
Meloxicam—Vomiting—Cisplatin—testicular cancer	0.000138	0.00061	CcSEcCtD
Meloxicam—Vision blurred—Methotrexate—testicular cancer	0.000138	0.000608	CcSEcCtD
Meloxicam—Mental disorder—Epirubicin—testicular cancer	0.000138	0.000607	CcSEcCtD
Meloxicam—Erythema multiforme—Doxorubicin—testicular cancer	0.000137	0.000607	CcSEcCtD
Meloxicam—Rash—Cisplatin—testicular cancer	0.000137	0.000605	CcSEcCtD
Meloxicam—Dermatitis—Cisplatin—testicular cancer	0.000137	0.000604	CcSEcCtD
Meloxicam—Erythema—Epirubicin—testicular cancer	0.000137	0.000604	CcSEcCtD
Meloxicam—Malnutrition—Epirubicin—testicular cancer	0.000137	0.000604	CcSEcCtD
Meloxicam—Diarrhoea—Etoposide—testicular cancer	0.000136	0.000601	CcSEcCtD
Meloxicam—Eye disorder—Doxorubicin—testicular cancer	0.000136	0.0006	CcSEcCtD
Meloxicam—Ill-defined disorder—Methotrexate—testicular cancer	0.000135	0.000598	CcSEcCtD
Meloxicam—Tinnitus—Doxorubicin—testicular cancer	0.000135	0.000598	CcSEcCtD
Meloxicam—Anaemia—Methotrexate—testicular cancer	0.000135	0.000596	CcSEcCtD
Meloxicam—Flushing—Doxorubicin—testicular cancer	0.000135	0.000595	CcSEcCtD
Meloxicam—Cardiac disorder—Doxorubicin—testicular cancer	0.000135	0.000595	CcSEcCtD
Meloxicam—Flatulence—Epirubicin—testicular cancer	0.000135	0.000595	CcSEcCtD
Meloxicam—Tension—Epirubicin—testicular cancer	0.000134	0.000592	CcSEcCtD
Meloxicam—Dysgeusia—Epirubicin—testicular cancer	0.000134	0.000591	CcSEcCtD
Meloxicam—Nervousness—Epirubicin—testicular cancer	0.000133	0.000586	CcSEcCtD
Meloxicam—Back pain—Epirubicin—testicular cancer	0.000132	0.000584	CcSEcCtD
Meloxicam—Angiopathy—Doxorubicin—testicular cancer	0.000132	0.000582	CcSEcCtD
Meloxicam—Malaise—Methotrexate—testicular cancer	0.000132	0.000582	CcSEcCtD
Meloxicam—Dizziness—Etoposide—testicular cancer	0.000132	0.000581	CcSEcCtD
Meloxicam—Muscle spasms—Epirubicin—testicular cancer	0.000131	0.00058	CcSEcCtD
Meloxicam—Immune system disorder—Doxorubicin—testicular cancer	0.000131	0.000579	CcSEcCtD
Meloxicam—Vertigo—Methotrexate—testicular cancer	0.000131	0.000579	CcSEcCtD
Meloxicam—Mediastinal disorder—Doxorubicin—testicular cancer	0.000131	0.000578	CcSEcCtD
Meloxicam—Leukopenia—Methotrexate—testicular cancer	0.000131	0.000577	CcSEcCtD
Meloxicam—Arrhythmia—Doxorubicin—testicular cancer	0.00013	0.000573	CcSEcCtD
Meloxicam—Nausea—Cisplatin—testicular cancer	0.000129	0.00057	CcSEcCtD
Meloxicam—Vision blurred—Epirubicin—testicular cancer	0.000129	0.000569	CcSEcCtD
Meloxicam—Alopecia—Doxorubicin—testicular cancer	0.000128	0.000567	CcSEcCtD
Meloxicam—Cough—Methotrexate—testicular cancer	0.000127	0.000563	CcSEcCtD
Meloxicam—Mental disorder—Doxorubicin—testicular cancer	0.000127	0.000562	CcSEcCtD
Meloxicam—Ill-defined disorder—Epirubicin—testicular cancer	0.000127	0.00056	CcSEcCtD
Meloxicam—Convulsion—Methotrexate—testicular cancer	0.000127	0.000559	CcSEcCtD
Meloxicam—Vomiting—Etoposide—testicular cancer	0.000127	0.000559	CcSEcCtD
Meloxicam—Erythema—Doxorubicin—testicular cancer	0.000126	0.000558	CcSEcCtD
Meloxicam—Malnutrition—Doxorubicin—testicular cancer	0.000126	0.000558	CcSEcCtD
Meloxicam—Anaemia—Epirubicin—testicular cancer	0.000126	0.000558	CcSEcCtD
Meloxicam—Rash—Etoposide—testicular cancer	0.000125	0.000554	CcSEcCtD
Meloxicam—Dermatitis—Etoposide—testicular cancer	0.000125	0.000554	CcSEcCtD
Meloxicam—Headache—Etoposide—testicular cancer	0.000125	0.000551	CcSEcCtD
Meloxicam—Flatulence—Doxorubicin—testicular cancer	0.000125	0.00055	CcSEcCtD
Meloxicam—Myalgia—Methotrexate—testicular cancer	0.000124	0.000549	CcSEcCtD
Meloxicam—Arthralgia—Methotrexate—testicular cancer	0.000124	0.000549	CcSEcCtD
Meloxicam—Tension—Doxorubicin—testicular cancer	0.000124	0.000548	CcSEcCtD
Meloxicam—Dysgeusia—Doxorubicin—testicular cancer	0.000124	0.000547	CcSEcCtD
Meloxicam—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000123	0.000545	CcSEcCtD
Meloxicam—Malaise—Epirubicin—testicular cancer	0.000123	0.000544	CcSEcCtD
Meloxicam—Discomfort—Methotrexate—testicular cancer	0.000123	0.000543	CcSEcCtD
Meloxicam—Nervousness—Doxorubicin—testicular cancer	0.000123	0.000542	CcSEcCtD
Meloxicam—Vertigo—Epirubicin—testicular cancer	0.000123	0.000542	CcSEcCtD
Meloxicam—Syncope—Epirubicin—testicular cancer	0.000123	0.000541	CcSEcCtD
Meloxicam—Leukopenia—Epirubicin—testicular cancer	0.000122	0.00054	CcSEcCtD
Meloxicam—Back pain—Doxorubicin—testicular cancer	0.000122	0.00054	CcSEcCtD
Meloxicam—Muscle spasms—Doxorubicin—testicular cancer	0.000122	0.000537	CcSEcCtD
Meloxicam—Palpitations—Epirubicin—testicular cancer	0.000121	0.000533	CcSEcCtD
Meloxicam—Confusional state—Methotrexate—testicular cancer	0.00012	0.000531	CcSEcCtD
Meloxicam—Loss of consciousness—Epirubicin—testicular cancer	0.00012	0.000531	CcSEcCtD
Meloxicam—Cough—Epirubicin—testicular cancer	0.000119	0.000527	CcSEcCtD
Meloxicam—Anaphylactic shock—Methotrexate—testicular cancer	0.000119	0.000526	CcSEcCtD
Meloxicam—Vision blurred—Doxorubicin—testicular cancer	0.000119	0.000526	CcSEcCtD
Meloxicam—Convulsion—Epirubicin—testicular cancer	0.000118	0.000523	CcSEcCtD
Meloxicam—Infection—Methotrexate—testicular cancer	0.000118	0.000523	CcSEcCtD
Meloxicam—Nausea—Etoposide—testicular cancer	0.000118	0.000522	CcSEcCtD
Meloxicam—Hypertension—Epirubicin—testicular cancer	0.000118	0.000521	CcSEcCtD
Meloxicam—Ill-defined disorder—Doxorubicin—testicular cancer	0.000117	0.000518	CcSEcCtD
Meloxicam—Nervous system disorder—Methotrexate—testicular cancer	0.000117	0.000516	CcSEcCtD
Meloxicam—Anaemia—Doxorubicin—testicular cancer	0.000117	0.000516	CcSEcCtD
Meloxicam—Thrombocytopenia—Methotrexate—testicular cancer	0.000117	0.000515	CcSEcCtD
Meloxicam—Arthralgia—Epirubicin—testicular cancer	0.000116	0.000514	CcSEcCtD
Meloxicam—Myalgia—Epirubicin—testicular cancer	0.000116	0.000514	CcSEcCtD
Meloxicam—Anxiety—Epirubicin—testicular cancer	0.000116	0.000512	CcSEcCtD
Meloxicam—Skin disorder—Methotrexate—testicular cancer	0.000116	0.000511	CcSEcCtD
Meloxicam—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000116	0.00051	CcSEcCtD
Meloxicam—Hyperhidrosis—Methotrexate—testicular cancer	0.000115	0.000509	CcSEcCtD
Meloxicam—Discomfort—Epirubicin—testicular cancer	0.000115	0.000508	CcSEcCtD
Meloxicam—Malaise—Doxorubicin—testicular cancer	0.000114	0.000504	CcSEcCtD
Meloxicam—Dry mouth—Epirubicin—testicular cancer	0.000114	0.000503	CcSEcCtD
Meloxicam—Vertigo—Doxorubicin—testicular cancer	0.000114	0.000502	CcSEcCtD
Meloxicam—Syncope—Doxorubicin—testicular cancer	0.000113	0.000501	CcSEcCtD
Meloxicam—Leukopenia—Doxorubicin—testicular cancer	0.000113	0.0005	CcSEcCtD
Meloxicam—Confusional state—Epirubicin—testicular cancer	0.000112	0.000497	CcSEcCtD
Meloxicam—Palpitations—Doxorubicin—testicular cancer	0.000112	0.000494	CcSEcCtD
Meloxicam—Oedema—Epirubicin—testicular cancer	0.000112	0.000493	CcSEcCtD
Meloxicam—Anaphylactic shock—Epirubicin—testicular cancer	0.000112	0.000493	CcSEcCtD
Meloxicam—Hypotension—Methotrexate—testicular cancer	0.000111	0.000492	CcSEcCtD
Meloxicam—Loss of consciousness—Doxorubicin—testicular cancer	0.000111	0.000491	CcSEcCtD
Meloxicam—Infection—Epirubicin—testicular cancer	0.000111	0.000489	CcSEcCtD
Meloxicam—Cough—Doxorubicin—testicular cancer	0.00011	0.000487	CcSEcCtD
Meloxicam—Shock—Epirubicin—testicular cancer	0.00011	0.000485	CcSEcCtD
Meloxicam—Convulsion—Doxorubicin—testicular cancer	0.00011	0.000484	CcSEcCtD
Meloxicam—Nervous system disorder—Epirubicin—testicular cancer	0.000109	0.000483	CcSEcCtD
Meloxicam—Thrombocytopenia—Epirubicin—testicular cancer	0.000109	0.000482	CcSEcCtD
Meloxicam—Hypertension—Doxorubicin—testicular cancer	0.000109	0.000482	CcSEcCtD
Meloxicam—Tachycardia—Epirubicin—testicular cancer	0.000109	0.000481	CcSEcCtD
Meloxicam—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000109	0.00048	CcSEcCtD
Meloxicam—Skin disorder—Epirubicin—testicular cancer	0.000108	0.000478	CcSEcCtD
Meloxicam—Hyperhidrosis—Epirubicin—testicular cancer	0.000108	0.000476	CcSEcCtD
Meloxicam—Insomnia—Methotrexate—testicular cancer	0.000108	0.000476	CcSEcCtD
Meloxicam—Arthralgia—Doxorubicin—testicular cancer	0.000108	0.000475	CcSEcCtD
Meloxicam—Myalgia—Doxorubicin—testicular cancer	0.000108	0.000475	CcSEcCtD
Meloxicam—Anxiety—Doxorubicin—testicular cancer	0.000107	0.000474	CcSEcCtD
Meloxicam—Paraesthesia—Methotrexate—testicular cancer	0.000107	0.000473	CcSEcCtD
Meloxicam—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000107	0.000472	CcSEcCtD
Meloxicam—Discomfort—Doxorubicin—testicular cancer	0.000106	0.00047	CcSEcCtD
Meloxicam—Dyspnoea—Methotrexate—testicular cancer	0.000106	0.000469	CcSEcCtD
Meloxicam—Somnolence—Methotrexate—testicular cancer	0.000106	0.000468	CcSEcCtD
Meloxicam—Dry mouth—Doxorubicin—testicular cancer	0.000105	0.000465	CcSEcCtD
Meloxicam—Dyspepsia—Methotrexate—testicular cancer	0.000105	0.000463	CcSEcCtD
Meloxicam—Hypotension—Epirubicin—testicular cancer	0.000104	0.00046	CcSEcCtD
Meloxicam—Confusional state—Doxorubicin—testicular cancer	0.000104	0.00046	CcSEcCtD
Meloxicam—Decreased appetite—Methotrexate—testicular cancer	0.000104	0.000458	CcSEcCtD
Meloxicam—Oedema—Doxorubicin—testicular cancer	0.000103	0.000456	CcSEcCtD
Meloxicam—Anaphylactic shock—Doxorubicin—testicular cancer	0.000103	0.000456	CcSEcCtD
Meloxicam—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000103	0.000454	CcSEcCtD
Meloxicam—Fatigue—Methotrexate—testicular cancer	0.000103	0.000454	CcSEcCtD
Meloxicam—Infection—Doxorubicin—testicular cancer	0.000103	0.000453	CcSEcCtD
Meloxicam—Pain—Methotrexate—testicular cancer	0.000102	0.00045	CcSEcCtD
Meloxicam—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000102	0.000449	CcSEcCtD
Meloxicam—Shock—Doxorubicin—testicular cancer	0.000102	0.000448	CcSEcCtD
Meloxicam—Nervous system disorder—Doxorubicin—testicular cancer	0.000101	0.000447	CcSEcCtD
Meloxicam—Thrombocytopenia—Doxorubicin—testicular cancer	0.000101	0.000446	CcSEcCtD
Meloxicam—Insomnia—Epirubicin—testicular cancer	0.000101	0.000446	CcSEcCtD
Meloxicam—Tachycardia—Doxorubicin—testicular cancer	0.000101	0.000445	CcSEcCtD
Meloxicam—Skin disorder—Doxorubicin—testicular cancer	0.0001	0.000443	CcSEcCtD
Meloxicam—Paraesthesia—Epirubicin—testicular cancer	0.0001	0.000442	CcSEcCtD
Meloxicam—Hyperhidrosis—Doxorubicin—testicular cancer	9.98e-05	0.000441	CcSEcCtD
Meloxicam—Dyspnoea—Epirubicin—testicular cancer	9.94e-05	0.000439	CcSEcCtD
Meloxicam—Somnolence—Epirubicin—testicular cancer	9.91e-05	0.000438	CcSEcCtD
Meloxicam—Feeling abnormal—Methotrexate—testicular cancer	9.82e-05	0.000434	CcSEcCtD
Meloxicam—Dyspepsia—Epirubicin—testicular cancer	9.82e-05	0.000434	CcSEcCtD
Meloxicam—Gastrointestinal pain—Methotrexate—testicular cancer	9.75e-05	0.00043	CcSEcCtD
Meloxicam—Decreased appetite—Epirubicin—testicular cancer	9.69e-05	0.000428	CcSEcCtD
Meloxicam—Hypotension—Doxorubicin—testicular cancer	9.64e-05	0.000426	CcSEcCtD
Meloxicam—Gastrointestinal disorder—Epirubicin—testicular cancer	9.63e-05	0.000425	CcSEcCtD
Meloxicam—Fatigue—Epirubicin—testicular cancer	9.62e-05	0.000425	CcSEcCtD
Meloxicam—Constipation—Epirubicin—testicular cancer	9.54e-05	0.000421	CcSEcCtD
Meloxicam—Pain—Epirubicin—testicular cancer	9.54e-05	0.000421	CcSEcCtD
Meloxicam—Urticaria—Methotrexate—testicular cancer	9.47e-05	0.000418	CcSEcCtD
Meloxicam—Body temperature increased—Methotrexate—testicular cancer	9.42e-05	0.000416	CcSEcCtD
Meloxicam—Abdominal pain—Methotrexate—testicular cancer	9.42e-05	0.000416	CcSEcCtD
Meloxicam—Musculoskeletal discomfort—Doxorubicin—testicular cancer	9.4e-05	0.000415	CcSEcCtD
Meloxicam—Insomnia—Doxorubicin—testicular cancer	9.33e-05	0.000412	CcSEcCtD
Meloxicam—Paraesthesia—Doxorubicin—testicular cancer	9.27e-05	0.000409	CcSEcCtD
Meloxicam—Dyspnoea—Doxorubicin—testicular cancer	9.2e-05	0.000406	CcSEcCtD
Meloxicam—Feeling abnormal—Epirubicin—testicular cancer	9.19e-05	0.000406	CcSEcCtD
Meloxicam—Somnolence—Doxorubicin—testicular cancer	9.17e-05	0.000405	CcSEcCtD
Meloxicam—Gastrointestinal pain—Epirubicin—testicular cancer	9.12e-05	0.000403	CcSEcCtD
Meloxicam—Dyspepsia—Doxorubicin—testicular cancer	9.08e-05	0.000401	CcSEcCtD
Meloxicam—Decreased appetite—Doxorubicin—testicular cancer	8.97e-05	0.000396	CcSEcCtD
Meloxicam—Gastrointestinal disorder—Doxorubicin—testicular cancer	8.91e-05	0.000394	CcSEcCtD
Meloxicam—Fatigue—Doxorubicin—testicular cancer	8.9e-05	0.000393	CcSEcCtD
Meloxicam—Urticaria—Epirubicin—testicular cancer	8.86e-05	0.000391	CcSEcCtD
Meloxicam—Pain—Doxorubicin—testicular cancer	8.82e-05	0.00039	CcSEcCtD
Meloxicam—Constipation—Doxorubicin—testicular cancer	8.82e-05	0.00039	CcSEcCtD
Meloxicam—Body temperature increased—Epirubicin—testicular cancer	8.82e-05	0.000389	CcSEcCtD
Meloxicam—Abdominal pain—Epirubicin—testicular cancer	8.82e-05	0.000389	CcSEcCtD
Meloxicam—Hypersensitivity—Methotrexate—testicular cancer	8.78e-05	0.000388	CcSEcCtD
Meloxicam—Asthenia—Methotrexate—testicular cancer	8.55e-05	0.000378	CcSEcCtD
Meloxicam—Feeling abnormal—Doxorubicin—testicular cancer	8.5e-05	0.000376	CcSEcCtD
Meloxicam—Gastrointestinal pain—Doxorubicin—testicular cancer	8.44e-05	0.000373	CcSEcCtD
Meloxicam—Pruritus—Methotrexate—testicular cancer	8.43e-05	0.000372	CcSEcCtD
Meloxicam—Hypersensitivity—Epirubicin—testicular cancer	8.22e-05	0.000363	CcSEcCtD
Meloxicam—Urticaria—Doxorubicin—testicular cancer	8.2e-05	0.000362	CcSEcCtD
Meloxicam—Abdominal pain—Doxorubicin—testicular cancer	8.16e-05	0.00036	CcSEcCtD
Meloxicam—Body temperature increased—Doxorubicin—testicular cancer	8.16e-05	0.00036	CcSEcCtD
Meloxicam—Diarrhoea—Methotrexate—testicular cancer	8.15e-05	0.00036	CcSEcCtD
Meloxicam—Asthenia—Epirubicin—testicular cancer	8e-05	0.000353	CcSEcCtD
Meloxicam—Pruritus—Epirubicin—testicular cancer	7.89e-05	0.000349	CcSEcCtD
Meloxicam—Dizziness—Methotrexate—testicular cancer	7.88e-05	0.000348	CcSEcCtD
Meloxicam—Diarrhoea—Epirubicin—testicular cancer	7.63e-05	0.000337	CcSEcCtD
Meloxicam—Hypersensitivity—Doxorubicin—testicular cancer	7.6e-05	0.000336	CcSEcCtD
Meloxicam—Vomiting—Methotrexate—testicular cancer	7.58e-05	0.000335	CcSEcCtD
Meloxicam—Rash—Methotrexate—testicular cancer	7.51e-05	0.000332	CcSEcCtD
Meloxicam—Dermatitis—Methotrexate—testicular cancer	7.51e-05	0.000332	CcSEcCtD
Meloxicam—Headache—Methotrexate—testicular cancer	7.47e-05	0.00033	CcSEcCtD
Meloxicam—Asthenia—Doxorubicin—testicular cancer	7.4e-05	0.000327	CcSEcCtD
Meloxicam—Dizziness—Epirubicin—testicular cancer	7.38e-05	0.000326	CcSEcCtD
Meloxicam—Pruritus—Doxorubicin—testicular cancer	7.3e-05	0.000322	CcSEcCtD
Meloxicam—Vomiting—Epirubicin—testicular cancer	7.09e-05	0.000313	CcSEcCtD
Meloxicam—Nausea—Methotrexate—testicular cancer	7.08e-05	0.000313	CcSEcCtD
Meloxicam—Diarrhoea—Doxorubicin—testicular cancer	7.06e-05	0.000312	CcSEcCtD
Meloxicam—Rash—Epirubicin—testicular cancer	7.03e-05	0.000311	CcSEcCtD
Meloxicam—Dermatitis—Epirubicin—testicular cancer	7.03e-05	0.00031	CcSEcCtD
Meloxicam—Headache—Epirubicin—testicular cancer	6.99e-05	0.000309	CcSEcCtD
Meloxicam—Dizziness—Doxorubicin—testicular cancer	6.82e-05	0.000301	CcSEcCtD
Meloxicam—Nausea—Epirubicin—testicular cancer	6.62e-05	0.000293	CcSEcCtD
Meloxicam—Vomiting—Doxorubicin—testicular cancer	6.56e-05	0.00029	CcSEcCtD
Meloxicam—Rash—Doxorubicin—testicular cancer	6.51e-05	0.000287	CcSEcCtD
Meloxicam—Dermatitis—Doxorubicin—testicular cancer	6.5e-05	0.000287	CcSEcCtD
Meloxicam—Headache—Doxorubicin—testicular cancer	6.46e-05	0.000286	CcSEcCtD
Meloxicam—Nausea—Doxorubicin—testicular cancer	6.13e-05	0.000271	CcSEcCtD
